GlassScriptPhysician profile
Prabhakar Pandey
NPI 1861491870
$6,096.00
in general payments reported to CMS, 2019-2025
42 companies · $931 in 2025
The $931 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,231 · 2020: $278 · 2021: $824 · 2022: $1,240 · 2023: $1,031 · 2024: $561 · 2025: $931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,510 · Education: $13.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,509.73 |
| Education | $13.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,549.77 | 2019-2025 | Moses 550 D\F\L, Lithovue, Axonics |
| Medtronic, INC. | $822.04 | 2021-2025 | Interstim, Altaviva |
| Smith+Nephew, INC. | $702.67 | 2021-2025 | Stravix, Grafix Pl |
| Myriad Genetic Laboratories, INC. | $326.40 | 2020-2023 | Prolaris |
| Intuitive Surgical, INC. | $313.79 | 2019-2024 | |
| Axonics, INC. | $273.26 | 2021-2023 | Axonics |
| Astellas Pharma US INC | $256.56 | 2019-2025 | Padcev |
| Coloplast Corp | $254.44 | 2021-2025 | Speedicath, Restorelle |
| Coopersurgical, INC. | $228.29 | 2019-2021 | |
| Janssen Biotech, INC. | $169.73 | 2019-2024 | Carvykti, Rybrevant |
| Ferring Pharmaceuticals INC. | $149.06 | 2024-2025 | Adstiladrin |
| Pfizer INC. | $83.48 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $78.35 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $77.79 | 2019-2025 | Keytruda, Welireg, Keytruda Qlex |
| C. R. Bard, INC. & Subsidiaries | $69.60 | 2020-2024 | Bard Urinary Drainage Bag |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prabhakar Pandey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.